A Case Series Follow-up of 15 Patients Living with Autoimmune Disease Treated With CAR T-Cell Therapy
Latest Information Update: 29 Feb 2024
At a glance
- Drugs KYV-101 (Primary)
- Indications Autoimmune disorders; Myositis; Systemic lupus erythematosus; Systemic scleroderma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 29 Feb 2024 New trial record
- 22 Feb 2024 According to a Kyverna Therapeutics media release, results of a case series follow-up of 15 patients living with autoimmune disease treated with CAR T-cell therapy published in the New England Journal of Medicine.